drugset / Trial / NCT03445468

Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

NCT03445468 ↗

Phase 3 Completed 379 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate the immunogenicity and safety of 'IL-YANG Quadrivalent Seasonal Influenza Vaccine' in healthy Korean children and adolescents.

Timeline

Start
2017-09-20
Primary completion
2017-12-29
Completion
2018-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator IL-YANG Flu Vaccine Prefilled Syringe Vaccine 0.5 ml Intramuscular
Subject IL-YANG Quadrivalent Influenza Vaccine Vaccine 0.5 ml Intramuscular

Indications